Infinity to Present at the 2013 JMP Securities Healthcare Conference
JMP Securities Healthcare Conference 2013
CAMBRIDGE, Mass. -- July 2, 2013
Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) will be presenting at the 2013
JMP Securities Healthcare Conference on July 9, 2013, at 1:00 p.m. ET in New
A live webcast of Infinity's presentation will be accessible on the
“investors/media” section of the company's website, www.infi.com, and will be
available for 30 days following the event.
About Infinity Pharmaceuticals, Inc.
Infinity is an innovative biopharmaceutical company dedicated to discovering,
developing and delivering best-in-class medicines to people with
difficult-to-treat diseases. Infinity combines proven scientific expertise
with a passion for developing novel small molecule drugs that target emerging
disease pathways. Infinity’s programs focused on the inhibition of
phosphoinositide-3-kinase and heat shock protein 90 are evidence of its
innovative approach to drug discovery and development. For more information on
Infinity, please refer to the company’s website at www.infi.com.
Infinity Pharmaceuticals, Inc.
Kate Murray, 617-453-1179
Press spacebar to pause and continue. Press esc to stop.